When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AKRO - Akero reports additional positive data on lead candidate in NASH patients
Akero Therapeutics Inc.
Akero Therapeutics (NASDAQ:AKRO) jumps +43% AH, after the company announce results of a 16-week analysis of secondary and exploratory endpoints from its Phase 2a BALANCED study of its lead candidate efruxifermin (EFX), formerly known as AKR-001, in nonalcoholic steatohepatitis (NASH) patients.
More news on: Akero Therapeutics, Inc., Healthcare stocks news, Stocks on the move,